Charles & Colvard (CTHR) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual shareholder meeting scheduled for October 13, 2025, at the principal office, with remote participation allowed.
Meeting ordered by North Carolina Business Court following a shareholder petition due to the absence of a timely annual meeting.
Only specific agenda items permitted: board elections, auditor ratification, advisory votes on executive compensation and its frequency.
Quorum defined as shareholders present in person or by proxy at the meeting.
Court retains jurisdiction for any disputes or issues related to the meeting or observer.
Voting matters and shareholder proposals
Shareholders may vote on board elections, auditor ratification, advisory say-on-pay, and frequency of say-on-pay votes.
No other shareholder proposals will be accepted for this meeting due to court order.
Deadline for director nominations and proxy solicitation notices is August 25, 2025.
RiverStyx Fund, LP is expected to nominate candidates for the board.
Board of directors and corporate governance
Board nominees include current directors Ruten Bhanderi, Anne M. Butler, Neal Goldman, Don O'Connell, and James Tu.
Director nominations must comply with company bylaws and SEC rules.
Inspector of elections will be Craig Colosso from Equiniti.
Latest events from Charles & Colvard
- Shareholders face a contested Board election and key governance votes amid ongoing financial challenges.CTHR
Proxy Filing1 Dec 2025 - Director nominations by a shareholder were invalidated; Board to recommend elections at the Annual Meeting.CTHR
Proxy Filing1 Dec 2025 - Proxy contest seeks to replace four directors to address financial and governance concerns.CTHR
Proxy Filing1 Dec 2025 - Shareholders face a contested Board election amid calls for leadership change and strategic overhaul.CTHR
Proxy Filing1 Dec 2025 - Riverstyx seeks board control with three nominees and challenges a dilutive stock issuance.CTHR
Proxy Filing1 Dec 2025 - Board recommends its director slate, annual say-on-pay, and cost-saving measures amid restructuring.CTHR
Proxy Filing1 Dec 2025 - FY2024 saw a 27% sales decline, $14.4M loss, and major liquidity risks for Charles & Colvard.CTHR
Q4 202430 Sep 2025